Experience

Davis Polk advised the representative of the joint book-running managers in connection with the offering by CRC Escrow Issuer, LLC and CRC Finco, Inc., both wholly owned subsidiaries…

Davis Polk advised the representatives of the underwriters in connection with the $122.4 million public offering of 4,800,000 shares of common stock by Flexion Therapeutics, Inc. The…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A/Regulation S offering of $325 million aggregate principal amount of 5.50% senior notes…

Davis Polk advised the joint book-running managers on a $1 billion SEC registered offering by General Motors Financial Company, Inc. of 1,000,000 shares of its fixed-to-floating rate…

Davis Polk advised the representatives of several underwriters on an SEC-registered offering by General Motors Company of $3 billion in aggregate principal amount of senior notes,…

Davis Polk advised the underwriters in connection with an SEC-registered secondary offering of 10,000,000 common shares of Orion Engineered Carbons S.A. by Kinove Luxembourg Holdings 1…

Davis Polk advised the joint book-running managers and initial purchasers on a Rule 144A and Regulation S offering by K. Hovnanian Enterprises, Inc. of $440 million aggregate principal…

Davis Polk advised the joint book-running managers on an SEC-registered offering by General Motors Financial Company, Inc. of $500 million aggregate principal amount of floating-rate senior…

Davis Polk advised the selling agents in connection with the establishment of General Motors Financial Company, Inc.’s SEC-registered retail medium-term notes program. The program initially…

Davis Polk advised the sole book-running manager of a $359.35 million SEC-registered offering of 5,000,000 shares of common stock of Alnylam Pharmaceuticals, Inc. Alnylam’s common stock is…